Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenib. 2014

Koji Miyahara, and Kazuhiro Nouso, and Yasuhiro Miyake, and Shinichiro Nakamura, and Shuntaro Obi, and Maho Amano, and Kazuko Hirose, and Shin-Ichiro Nishimura, and Kazuhide Yamamoto
Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D005260 Female Females
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D054794 Glycomics The systematic study of the structure and function of the complete set of glycans (the glycome) produced in a single organism and identification of all the genes that encode glycoproteins. Sugar Code,Glycobiology

Related Publications

Koji Miyahara, and Kazuhiro Nouso, and Yasuhiro Miyake, and Shinichiro Nakamura, and Shuntaro Obi, and Maho Amano, and Kazuko Hirose, and Shin-Ichiro Nishimura, and Kazuhide Yamamoto
May 2017, Hepatology research : the official journal of the Japan Society of Hepatology,
Koji Miyahara, and Kazuhiro Nouso, and Yasuhiro Miyake, and Shinichiro Nakamura, and Shuntaro Obi, and Maho Amano, and Kazuko Hirose, and Shin-Ichiro Nishimura, and Kazuhide Yamamoto
October 2011, Alimentary pharmacology & therapeutics,
Koji Miyahara, and Kazuhiro Nouso, and Yasuhiro Miyake, and Shinichiro Nakamura, and Shuntaro Obi, and Maho Amano, and Kazuko Hirose, and Shin-Ichiro Nishimura, and Kazuhide Yamamoto
September 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Koji Miyahara, and Kazuhiro Nouso, and Yasuhiro Miyake, and Shinichiro Nakamura, and Shuntaro Obi, and Maho Amano, and Kazuko Hirose, and Shin-Ichiro Nishimura, and Kazuhide Yamamoto
January 2011, Oncology,
Koji Miyahara, and Kazuhiro Nouso, and Yasuhiro Miyake, and Shinichiro Nakamura, and Shuntaro Obi, and Maho Amano, and Kazuko Hirose, and Shin-Ichiro Nishimura, and Kazuhide Yamamoto
May 2021, Cancers,
Koji Miyahara, and Kazuhiro Nouso, and Yasuhiro Miyake, and Shinichiro Nakamura, and Shuntaro Obi, and Maho Amano, and Kazuko Hirose, and Shin-Ichiro Nishimura, and Kazuhide Yamamoto
March 2013, Molecular and clinical oncology,
Koji Miyahara, and Kazuhiro Nouso, and Yasuhiro Miyake, and Shinichiro Nakamura, and Shuntaro Obi, and Maho Amano, and Kazuko Hirose, and Shin-Ichiro Nishimura, and Kazuhide Yamamoto
January 2021, Clinical and translational gastroenterology,
Koji Miyahara, and Kazuhiro Nouso, and Yasuhiro Miyake, and Shinichiro Nakamura, and Shuntaro Obi, and Maho Amano, and Kazuko Hirose, and Shin-Ichiro Nishimura, and Kazuhide Yamamoto
November 2017, Molecular and clinical oncology,
Koji Miyahara, and Kazuhiro Nouso, and Yasuhiro Miyake, and Shinichiro Nakamura, and Shuntaro Obi, and Maho Amano, and Kazuko Hirose, and Shin-Ichiro Nishimura, and Kazuhide Yamamoto
January 2020, PloS one,
Koji Miyahara, and Kazuhiro Nouso, and Yasuhiro Miyake, and Shinichiro Nakamura, and Shuntaro Obi, and Maho Amano, and Kazuko Hirose, and Shin-Ichiro Nishimura, and Kazuhide Yamamoto
August 2013, American journal of clinical oncology,
Copied contents to your clipboard!